Radiosynthesis, Biological Evaluation, and Preclinical Study of a 68Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed αvβ3 Integrin Receptors in Non-Small-Cell Lung Cancer

<div>HPLC profile of [68Ga]Ga-DOTA-E(cRGDfK)2. The peaks at 2.54 and 10.59 min are related to free 68Ga and [68Ga]Ga-DOTA-E(cRGDfK)2, respectively.</div>

Contrast Media & Molecular Imaging

fig2

Figure 2

Figure 2: Radiosynthesis, Biological Evaluation, and Preclinical Study of a 68Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed αvβ3 Integrin Receptors in Non-Small-Cell Lung Cancer

Figure 2 | Radiosynthesis, Biological Evaluation, and Preclinical Study of a 68Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed αvβ3 Integrin Receptors in Non-Small-Cell Lung Cancer 